Erlotinib-induced trichomegaly in a male patient with pancreatic cancer
| Autor: | Joseph Gnanaraj, Muhammad Wasif Saif |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
Oncology medicine.medical_specialty Hypertrichosis Antineoplastic Agents Toxicology Erlotinib Hydrochloride Internal medicine Pancreatic cancer medicine Humans Trichomegaly Epidermal growth factor receptor Lung cancer Protein Kinase Inhibitors Aged EGFR inhibitors Eyelashes biology business.industry Cancer General Medicine Middle Aged medicine.disease respiratory tract diseases ErbB Receptors Pancreatic Neoplasms Quinazolines biology.protein Female Erlotinib Eyebrows medicine.symptom business medicine.drug |
| Zdroj: | Cutaneous and Ocular Toxicology. 29:62-66 |
| ISSN: | 1556-9535 1556-9527 |
| Popis: | In this report we present a case of erlotinib-induced trichomegaly in a male patient who received erlotinib for his pancreatic cancer. Trichomegaly as a side effect of epidermal growth factor receptor (EGFR) inhibitor therapy is uncommon in male patients. Also, it has not been reported previously in a patient with pancreatic cancer. Previous reported cases all involved female lung cancer patients. We emphasize the importance of recognizing the side effects of EGFR inhibitor therapy and its implications on the prognosis of the cancer treated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|